Loading organizations...
Key people at Sunshine Riverhead Capital.
Sunshine Riverhead Capital operates as the dedicated private equity arm of Sunshine Insurance Group, specializing in fund management. It strategically invests in healthcare and emerging technology sectors, deploying parent company capital to foster innovation and growth. This structure efficiently channels substantial insurance funds into promising enterprises within China's dynamic market.
Established in January 2015, the firm was founded directly by the Sunshine Insurance Group. Its creation marked a pioneering moment, becoming one of China's first private equity fund managers initiated by insurance funds. This strategic insight diversified insurance capital into high-growth industries, establishing a robust investment platform.
The company primarily supports enterprises within healthcare and advanced technology, providing crucial growth capital. Sunshine Riverhead Capital empowers founders developing transformative technologies for positive societal impact. Its vision is to be a leading investment force, driving innovation and delivering strong returns by backing future industries.
Key people at Sunshine Riverhead Capital.
Sunshine Riverhead Capital has 3 tracked investments across 3 companies. The latest tracked deal is $39.8M Series B in TYK Medicines in December 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 15, 2020 | TYK Medicines | $39.8M Series B | — | — |
| Jun 8, 2020 | ESWIN Computing | $282.5M Other Equity | IDG Capital, Legend Capital | — |
| Mar 20, 2017 | Tsing Pu | $29.0M Series A | Sunshine Riverhead Capital | — |